Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
May 2006
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31
Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Selectively blocking inflammatory signals may protect mice from MS
A new way to preserve the cells that surround and protect nerves could lead to new treatments for demyelinating diseases such a multiple sclerosis, a research team reports   more »
View Article  T-Cell Levels Believed to Help in Multiple Sclerosis
Oral Presentation at American Academy of Neurology CARLSBAD, C.A. -- The Immune Response Corporation (OTCBB:IMNR.OB) announced that its T-cell receptor peptide vaccine candidate, NeuroVax™, induces increased FOXP3 expression resulting in re- establishment of normal levels of the FOXP3+ regulatory T-cells believed to be important in controlling the development of multiple sclerosis (MS). Results of the recently completed open-label trial   more »
View Article  Long-Term Data for Fingolimod Show Significant Efficacy and Safety in Preventing MS Relapse:
New data from a phase 2 study of FTY720, (fingolimod) show a better than 50% reduction in the annualized relapse rate in patients with relapsing- remitting multiple sclerosis (MS). The results were   more »